These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat. Ballermann BJ; Bloch KD; Seidman JG; Brenner BM J Clin Invest; 1986 Sep; 78(3):840-3. PubMed ID: 3018046 [TBL] [Abstract][Full Text] [Related]
4. Plasma levels of atrial natriuretic peptide (ANP) during mineralocorticoid escape in normal man. Wambach G; Götz S; Suckau G; Kaufmann W Klin Wochenschr; 1986; 64 Suppl 6():53-7. PubMed ID: 2948064 [TBL] [Abstract][Full Text] [Related]
5. Antisera to atrial natriuretic factor reduces urinary sodium excretion and increases plasma renin activity in rats. Naruse M; Obana K; Naruse K; Sugino N; Demura H; Shizume K; Inagami T Biochem Biophys Res Commun; 1985 Nov; 132(3):954-60. PubMed ID: 2934063 [TBL] [Abstract][Full Text] [Related]
6. Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment. Lee YJ; Shin SJ; Tan MS; Hsieh TJ; Tsai JH Am J Physiol; 1996 Oct; 271(4 Pt 2):F779-89. PubMed ID: 8898007 [TBL] [Abstract][Full Text] [Related]
7. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats. Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622 [TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway. Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539 [TBL] [Abstract][Full Text] [Related]
9. Central effects of antiserum against human atrial natriuretic polypeptide on water and electrolyte metabolism and plasma arginine-8-vasopressin level in conscious rats. Laczi F; Szabó G; Jójárt I; Vecsernyés M; Csáti S; Kovács GL; Szarvas F; Telegdy G Neuropeptides; 1991 Jul; 19(3):183-7. PubMed ID: 1832749 [TBL] [Abstract][Full Text] [Related]
11. Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody. Itoh H; Nakao K; Mukoyama M; Arai H; Yamada T; Saito Y; Shiono S; Hosoda K; Shirakami G; Suga S Am J Hypertens; 1991 Jan; 4(1 Pt 1):39-44. PubMed ID: 1706603 [TBL] [Abstract][Full Text] [Related]
12. Sodium excretion and atrial natriuretic peptide levels during mineralocorticoid administration. A mechanism for the escape from hyperaldosteronism. Kelly TM; Nelson DH Endocr Res; 1987; 13(4):363-83. PubMed ID: 2966064 [TBL] [Abstract][Full Text] [Related]
13. Increased synthesis and release of atrial peptide during DOCA escape in conscious dogs. Metzler CH; Gardner DG; Keil LC; Baxter JD; Ramsay DJ Am J Physiol; 1987 Jan; 252(1 Pt 2):R188-92. PubMed ID: 2949629 [TBL] [Abstract][Full Text] [Related]
14. Changes in the plasma levels of atrial natriuretic peptides during mineralocorticoid escape in man. Cappuccio FP; Markandu ND; Buckley MG; Sagnella GA; Shore AC; MacGregor GA Clin Sci (Lond); 1987 May; 72(5):531-9. PubMed ID: 2953526 [TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunction. Costello-Boerrigter LC; Boerrigter G; Harty GJ; Cataliotti A; Redfield MM; Burnett JC Hypertension; 2007 Sep; 50(3):481-8. PubMed ID: 17635858 [TBL] [Abstract][Full Text] [Related]
16. Specific binding of atrial natriuretic factor to renal glomeruli in Doca- and Doca-salt-treated rats correlation with atrial and plasma levels. Gauquelin G; Schiffrin EL; Cantin M; Garcia R Biochem Biophys Res Commun; 1987 May; 145(1):522-31. PubMed ID: 3036134 [TBL] [Abstract][Full Text] [Related]
17. Phasic plasma atrial natriuretic polypeptide changes in DOCA-salt hypertensive rats. Sato Y; Ito Y; Ando K; Ogata E; Fujita T Jpn Heart J; 1990 Sep; 31(5):703-11. PubMed ID: 2148777 [TBL] [Abstract][Full Text] [Related]
18. Role of atrial natriuretic peptide on sodium homeostasis in experimental renal failure. Nitta K; Naruse M; Sanaka T; Tsuchiya K; Sugino N Jpn J Exp Med; 1989 Oct; 59(5):181-8. PubMed ID: 2533287 [TBL] [Abstract][Full Text] [Related]
19. Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats. Bae EH; Kim IJ; Ma SK; Kim SW Regul Pept; 2009 Oct; 157(1-3):76-83. PubMed ID: 19422859 [TBL] [Abstract][Full Text] [Related]
20. Effects of calcium supplementation and deoxycorticosterone on plasma atrial natriuretic peptide and electrolyte excretion in spontaneously hypertensive rats. Pörsti I; Wuorela H; Arvola P; Mämmi P; Nurmi AK; Koistinaho J; Laippala P; Vapaatalo H Acta Physiol Scand; 1991 Mar; 141(3):343-50. PubMed ID: 1830445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]